Cardinal Health beat expectations with Q1 FY27 revenue and EPS growth, and raised its non-GAAP EPS guidance for the year. The company also completed a $500 million share repurchase program during the quarter.
Cardinal Health beat expectations with Q1 FY27 revenue and EPS growth, and raised its non-GAAP EPS guidance for the year. The company also completed a $500 million share repurchase program during the quarter.